These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 39363900)
1. A comprehensive prediction model for central lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis: BRAF may not be a valuable predictor. Chen Y; Zhao S; Zhang Z; Chen Z; Jiang B; An M; Shang M; Wu X; Zhang X; Chen B Front Endocrinol (Lausanne); 2024; 15():1429382. PubMed ID: 39363900 [TBL] [Abstract][Full Text] [Related]
2. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma. Liu Y; Lv H; Zhang S; Shi B; Sun Y Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817 [TBL] [Abstract][Full Text] [Related]
3. Predicting central cervical lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis: a practical nomogram based on retrospective study. Wang L; Zhang L; Wang D; Chen J; Su W; Sun L; Jiang J; Wang J; Zhou Q PeerJ; 2024; 12():e17108. PubMed ID: 38650652 [TBL] [Abstract][Full Text] [Related]
5. The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis. Lin Y; Cui N; Li F; Wang Y; Wang B Front Endocrinol (Lausanne); 2024; 15():1330896. PubMed ID: 38745958 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study. Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112 [TBL] [Abstract][Full Text] [Related]
7. Prediction Model of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma. Chen H; Zhu L; Zhuang Y; Ye X; Chen F; Zeng J Cancer Control; 2024; 31():10732748241295347. PubMed ID: 39425895 [TBL] [Abstract][Full Text] [Related]
8. An Online Model for Central Lymph Node Metastases in Papillary Thyroid Carcinoma With BRAF V600E Mutation. Chen H; Pan WK; Ren SY; Zhou YL Am J Clin Oncol; 2024 Aug; 47(8):383-390. PubMed ID: 38664891 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and Impact of BRAF mutation in patients with concomitant papillary thyroid carcinoma and Hashimoto's thyroiditis: a systematic review with meta-analysis. Janicki L; Patel A; Jendrzejewski J; Hellmann A Front Endocrinol (Lausanne); 2023; 14():1273498. PubMed ID: 38047109 [TBL] [Abstract][Full Text] [Related]
11. Hashimoto's Thyroiditis Is Associated With Central Lymph Node Metastasis in Classical Papillary Thyroid Cancer: Analysis from a High-Volume Single-Center Experience. Zeng B; Min Y; Feng Y; Xiang K; Chen H; Lin Z Front Endocrinol (Lausanne); 2022; 13():868606. PubMed ID: 35692401 [TBL] [Abstract][Full Text] [Related]
12. Ultrasound-based radiomics nomogram combined with clinical features for the prediction of central lymph node metastasis in papillary thyroid carcinoma patients with Hashimoto's thyroiditis. Jin P; Chen J; Dong Y; Zhang C; Chen Y; Zhang C; Qiu F; Zhang C; Huang P Front Endocrinol (Lausanne); 2022; 13():993564. PubMed ID: 36060946 [TBL] [Abstract][Full Text] [Related]
13. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study. Zhu F; Shen YB; Li FQ; Fang Y; Hu L; Wu YJ Medicine (Baltimore); 2016 Feb; 95(6):e2674. PubMed ID: 26871795 [TBL] [Abstract][Full Text] [Related]
14. Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0). Gao X; Luo W; He L; Cheng J; Yang L Front Endocrinol (Lausanne); 2021; 12():789310. PubMed ID: 35154002 [TBL] [Abstract][Full Text] [Related]
15. A nomogram model based on the preoperative clinical characteristics of papillary thyroid carcinoma with Hashimoto's thyroiditis to predict central lymph node metastasis. Zhao W; He L; Zhu J; Su A Clin Endocrinol (Oxf); 2021 Feb; 94(2):310-321. PubMed ID: 32984984 [TBL] [Abstract][Full Text] [Related]
16. Sonographic characteristics and clinical characteristics combined with nomogram for predicting the aggressiveness of papillary thyroid carcinoma coexisted with Hashimoto's thyroiditis. Zhao S; Zhang Z; Zhang X; Wu X; Chen Y; Min X; Chen B Braz J Otorhinolaryngol; 2024; 90(5):101456. PubMed ID: 38968750 [TBL] [Abstract][Full Text] [Related]
17. Correlation Between the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated with Hashimoto's Thyroiditis, BRAF V600E Gene Mutation, and RET Gene Rearrangement. Xie M; Xu ZX; Dai M; Zhu YY J Coll Physicians Surg Pak; 2024 Apr; 34(4):445-450. PubMed ID: 38576288 [TBL] [Abstract][Full Text] [Related]
18. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis. Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253 [TBL] [Abstract][Full Text] [Related]
19. Predicting factors of central lymph node metastasis and BRAF Zhou SL; Guo YP; Zhang L; Deng T; Xu ZG; Ding C; Sun WC; Zhao YW; Kong LF World J Surg Oncol; 2021 Jul; 19(1):211. PubMed ID: 34256769 [TBL] [Abstract][Full Text] [Related]
20. Sonographic Characteristics of Papillary Thyroid Carcinoma With Coexistent Hashimoto's Thyroiditis in the Preoperative Prediction of Central Lymph Node Metastasis. Chen S; Niu C; Peng Q; Tang K Front Endocrinol (Lausanne); 2021; 12():556851. PubMed ID: 33796065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]